1. Home
  2. Health
  3. Health Topics A-Z

From About.com

About.com Health's Disease and Condition content is reviewed by our Medical Review Board

ENCYCLOPEDIA INDEX
Injury Disease Nutrition Poison Symptoms Surgery Test Special Topic
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Hairy cell leukemia

Overview Symptoms Treatment Prevention
Alternative Names:
Leukemic reticuloendotheliosis; HCL
Treatment:

Early in the course of the disease, no treatment may be necessary. Some patients may need an occasional blood transfusion.

If treatment is needed because of very low blood counts, a variety of chemotherapy drugs (cladribine, pentostatin) can be used. Interferon is also used. In the majority of cases these drugs can produce a remission (complete relief from the disease) that lasts for many years. It is unclear if chemotherapy will cure the disease, however, because most patients will relapse over time.

The removal of the spleen may improve blood counts, but is unlikely to cure the disease. Symptomatic treatment of infections with antibiotics or low blood counts with growth factors and transfusions may be required.

Expectations (prognosis):
Newer treatments using chemotherapy have greatly improved the survival of patients with hairy cell leukemia. Most patients with hairy cell leukemia can expect to live 10 years or longer with the disease.
Complications:
The low blood counts caused by hairy cell leukemia can lead to infections, fatigue, and excessive bleeding.
Calling your health care provider:
Call your health care provider if significant bleeding occurs. Also call if signs of infection are present, including: persistent fever, cough, or general ill feeling.
Bone marrow aspiration
Bone marrow aspiration
Auer rods
Auer rods
Hairy cell leukemia - microscopic view
Hairy cell leukemia - microscopic view
Formed elements of blood
Formed elements of blood
Enlarged spleen
Enlarged spleen
adam.com

Explore Health Topics A-Z

More from About.com

  1. Home
  2. Health
  3. Health Topics A-Z

©2008 About.com, a part of The New York Times Company.

All rights reserved.